Skip to main content
. 2022 Jul 21;55:102416. doi: 10.1016/j.redox.2022.102416

Table 1.

Description and origin of the human dermal fibroblasts used in the present study. Control cells: CC; cells from individuals with Down syndrome: DSC; y: year; ∂: siblings; *: twins.

Reference ID Group ID Dot/Blot ID Origin Description Gender Age at sampling
CCD1064Sk CC C1 LGC Standards Diploid Male <1y
3-FCYPR10000286* CC C2 Jérôme Lejeune Institute Diploid Male 5 y
GM05756 CC C3 Coriell Institute Diploid Male <1y
GM05659 CC C4 Coriell Institute Diploid Male 1 y
Detroit 551 CC C5 LGC Standards Diploid Female <1y
1-FCYPR10000368 CC C6 Jérôme Lejeune Institute Diploid Female 12 y
GM00041 CC C7 Coriell Institute Diploid Female <1y
GM00969 CC C8 Coriell Institute Diploid Female <1y
Detroit 532 DSC D1 LGC Standards Trisomy 21 Male <1y
3-FCYPR10000285* DSC D2 Jérôme Lejeune Institute Trisomy 21 Male 5 y
AG07096 DSC D3 Coriell Institute Trisomy 21 Male <1y
AG05397 DSC D4 Coriell Institute Trisomy 21 Male 1 y
Detroit 539 DSC D5 LGC Standards Trisomy 21 Female 2 y
3-FCYPR10000369 DSC D6 Jérôme Lejeune Institute Trisomy 21 Female 9 y
GM02571 DSC D7 Coriell Institute Trisomy 21 Female <1y
GM04616 DSC D8 Coriell Institute Trisomy 21 Female <1y